Phospholipid scramblase 1 potentiates the antiviral activity of interferon

Journal of Virology

Volumn 78, Issue 17, 2004, Pages 8983-8993

  Dong, Beihua ^a   Zhou, Quansheng ^c   Zhao, Ji ^c   Zhou, Aimin ^b   Harty, Ronald N ^d   Bose, Santanu ^a   Banerjee, Amiya ^a   Slee, Roger ^a   Guenther, Jeanna ^a   Williams, Bryan R G ^a   Wiedmer, Therese ^c   Sims, Peter J ^c   Silverman, Robert H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; CALCIUM BINDING PROTEIN; GENE PRODUCT; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON; MEMBRANE PROTEIN; PHOSPHOLIPID; PHOSPHOLIPID SCRAMBLASE 1; PROTEIN P56; PROTEIN TYROSINE KINASE; SCRAMBLASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; ENZYME SUBSTRATE; FIBROBLAST; GENE; GENE EXPRESSION; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTERFERON STIMULATED GENE; ISG15 GENE; ISG54 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN STRUCTURE; STEM CELL; TRANSCRIPTION REGULATION; VESICULAR STOMATITIS VIRUS; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CARRIER PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; DNA-BINDING PROTEINS; EIF-2 KINASE; ENCEPHALOMYOCARDITIS VIRUS; FIBROBLASTS; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PHOSPHOLIPID TRANSFER PROTEINS; PROTEINS; RNA, SMALL INTERFERING; RNA, VIRAL; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

EID: 4143114613     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.17.8983-8993.2004     Document Type: Article

References (51)

1. Anderson, S. L., J. M. Carton, J. Lou, L. Xing, and B. Y. Rubin. 1999. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an anti-viral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256:8-14.
2. Balachandran, S., P. C. Roberts, L. E. Brown, H. Truong, A. K. Pattnaik, D. R. Archer, and G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141.
3. Barenholz, Y., R. Pal, and R. R. Wagner. 1993. Metabolic labeling of viral membrane lipids by fluorescent fatty acids: studying virus fusion with target membranes. Methods Enzymol. 220:288-312.
4. Baumal, R., J. Law, R. N. Buick, H. Kahn, H. Yeger, K. Sheldon, T. Colgan, and A. Marks. 1986. Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line. Cancer Res. 46:3994-4000.
5. Belkowski, L., and G. C. Sen. 1987. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J. Virol. 61:653-660.
6. Ben-Efraim, I., Q. Zhou, T. Wiedmer, L. Gerare, and P. J. Sims. 2004. Phospholipid scramblase 1 (PLSCR1) is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. Biochemistry 43:3518-3526.
7. Biron, C. A., and G. C. Sen. 2001. Interferons and other cytokines. p. 321-351. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
8. Bose, S., M. Mathur, P. Bates, N. Joshi, and A. K. Banerjee. 2003. Requirement for cydophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol. 84:1687-1699.
9. Bridge, A. J., S. Pebernard, A. Ducraux, A. L. Nicoulaz, and R. Iggo. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:263-264.
10. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
11. D'Cunha, J., S. Ramanujam, R. J. Wagner, P. L. Witt, E. Knight, Jr., and E. R. Borden. 1986. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157:4100-4108.
12. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman, 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
13. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H. Silverman, and B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
14. Faded, B., B. Gleiss, K. Hogstrand, J. Chandra, T. Wiedmer, P. J. Sims, J. I. Henter, S. Orrenius, and A. Samali. 1999. Phosphatidylserine exposure during apoptosis is a ceel-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem. Biophys. Res. Commun. 266:504-511.
15. Frevel, M. A., T. Bakheet, A. M. Silva, J. G. Hissong, K. S. Khabar, and B. R. Williams. 2003. p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell. Biol. 23:425-436.
16. Guo, J., K. L. Peters, and G. C. Sen. 2000. Induction of the human protein p56 by interferon, double-stranded RNA or virus infection. Virology 267:209-219.
17. Harty, R. N., M. E. Brown, J. P. McGettigan, G. Wang, H. R. Jayakar, J. M. Huibregtse, M. A. Whitt, and M. J. Schnell. 2001. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J. Virol. 75:10623-10629.
18. Harty, R. N., J. Paragas, M. Sudot, and P. Palese. 1999. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J. Virol. 73:2921-2929.
19. Hui, D. J., C. R. Bhasker, W. C. Merrick, and G. C. Sen. 2003. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP. Met-tRNAi. J. Biol. Chem. 278:39477-39482.
20. Hwang, L. N., N. Englund, T. Das, and A. K. Banerjee. 1999. Optimal replication of vesicular stomatitis virus RNA polymerase require phosphorylation of a residue(s) at carboxy-terminal domain II of its accessory subunit, phosphoprotein P. J. Virol. 73:5613-5620.
21. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147:258-267.
22. Jay, F. T., M. R. Dawood, and R. M. Friedman. 1983. Interferon induces the production of membrane protein-deficient and infectivity-defective vesicular stomatitis virions through interference in the virion assembly process. J. Gen. Virol. 64:707-712.
23. Jayakar, H. R., K. G. Murti, and M. A. Whitt. 2000. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 74:9818-9827.
24. Kasukabe, T., H. Kobayashi, Y. Kaneko, J. Okabe-Kado, and Y. Honma. 1998. Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis- associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene. Biochem. Biophys. Res. Commun. 249:449-455.
25. Kasukabe, T., J. Okabe-Kado, and V. Honma. 1997. TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in non-leukemogenic sublines. Blood 89:2975-2985.
26. Kim, K. I., and D. E. Zhang. 2003. ISG15, not just another ubiquitin-like protein. Biochem. Biophys. Res. Commun. 307:431-434.
27. Levy, D. E., I. Marie, E. Smith, and A. Prakash. 2002. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 22:87-93.
28. Malakhova, O. A., M. Yan, M. P. Malakhov, Y. Yuan, K. J. Ritchie, K. I. Kim, L. F. Peterson, K. Shuai, and D. E. Zhang. 2003. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17:455-160.
29. Mathur, M., T. Das, and A. K. Banerjee. 1996. Expression of L protein of vesicular stomatitis virus Indiana serotype from recombinant baculovirus in insect cells: requirement of a host factor(s) for its biological activity in vitro. J. Virol. 70:2252-2259.
30. Nanjundan, M., J. Sun, J. Zhao, Q. Zhou, P. J. Sims, and T. Wiedmer. 2003. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor. J. Biol. Chem. 278:37413-37418.
31. Nguyen, T. T., Y. Hu, D. P. Widney, R. A. Mar, and J. B. Smith. 2002. Murine GBP-5, a new member of the murine guanylate-binding protein family, is coordinately regulated with other GBPs in vivo and in vitro. J. Interferon Cytokine Res. 22:899-909.
32. Pasiorelli, C., J. Veiga, N. Charles, E. Voignier, H. Moussu, R. C. Monteiro, and M. Benhamou. 2001. IgE receptor type 1-dependent tyrosine phosphorylation of phospholipid scramblase. J. Biol. Chem. 276:20407-20412.
33. Pattnaik, A. K., and G. W. Wertz. 1990. Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. J. Virol. 64:2948-2957.
34. Sahni, G., and C. E. Samuel. 1986. Mechanism of interferon action. Expression of vesicular stomatitis virus G gene in transfected COS cells is inhibited by interferon at the level of protein synthesis. J. Biol. Chem. 261:16764-16768.
35. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
36. Silverman, R. H. 2003. Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812.
37. Silverman, R. H., A. Halloum, A. Zhou, B. Dong, F. Al-Zoghaibi, D. Kushner, Q. Zhou, J. Zhao, T. Wiedmer, and P. J. Sims. 2002. Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1. Cancer Res. 62:397-402.
38. Sims, P. J., and T. Wiedmer. 2001. Unraveling the mysteries of phospholipid scrambling. Thromb. Haemost. 86:266-275.
39. Stedz, C. A., M. Holko, M. J. de Veer, R. H. Silverman, and B. R. Williams. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-839.
40. Sun, J., M. Nanjundan, L. J. Pike, T. Wiedmer, and P. J. Sims. 2002. Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor. Biochemistry 41:6338-6345.
41. Sun, J., J. Zhao, M. A. Schwartz, J. Y. Wang, T. Wiedmer, and P. J. Sims. 2001. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1. J. Biol. Chem. 276:28984-28990.
42. Vestal, D. J., V. Y. Gorbacheva, and G. C. Sen. 2000. Different subcellular localizations for the related interferon-induced GTPases, mGBP-1 and mGDP-2: implications for different functions? J. Interferon Cytokine Res. 20:991-1000.
43. Wang, E., L. D. Miller, G. A. Ohnmacht, E. T. Liu, and F. M. Marincola. 2000. High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol. 18:457-459.
44. Wiedmer, T., J. Zhao, M. Nanjundan, and P. J. Sims. 2003. Palmitoylation of phospholipid scramblase 1 controls its distribution between nucleus and plasma membrane. Biochemistry 42:1227-12233.
45. Xiang, Y., R. C. Condit, S. Vijaysri, B. Jacobs, B. R. G. Williams, and R. H. Silverman. 2002. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76:5251-5259.
46. Yokoyama, A., T. Yamashita, E. Shiozawa, A. Nagasawa, J. Okabe-Kado, T. Nakamaki, S. Tomoyasu, F. Kimura, K. Motoyoshi, Y. Honma, and T. Kasukabe. 2004. MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia. Leuk. Res. 28:149-157.
47. Yuan, W., and R. M. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-371.
48. Zhou, A., J. M. Paranjape, S. D. Der, B. R. Williams, and R. H. Silverman. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440.
49. Zhou, Q., J. Zhao, F. Al-Zoghaibi, A. Zhou, T. Wiedmer, R. H. Silverman, and P. J. Sims. 2000. Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha. Blood 95:2593-2599.
50. Zhou, Q., J. Zhao, J. G. Stout, R. A. Luhm, T. Wiedmer, and P. J. Sims. 1997. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 272:18240-18244.
51. Zhou, Q., J. Zhao, T. Wiedmer, and P. J. Sims. 2002. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99:4030-4038.